Resultats de la cerca - Yufan Zhao
- Mostrar 1 - 10 resultats de 10
-
1
Reinforcement learning design for cancer clinical trials per Yufan Zhao, Michael R. Kosorok, Donglin Zeng
Publicat 2009Artigo -
2
-
3
-
4
-
5
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma per Geoffrey T. Gibney, Omid Hamid, Jose Lutzky, Anthony J. Olszanski, Tara C. Mitchell, Thomas F. Gajewski, Bartosz Chmielowski, Brent A. Hanks, Yufan Zhao, Robert Newton, Janet Maleski, Lance Leopold, Jeffrey S. Weber
Publicat 2019Artigo -
6
Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers per Tara C. Gangadhar, Omid Hamid, David C. Smith, Todd M. Bauer, Jeffrey S. Wasser, Jason J. Luke, Ani Sarkis Balmanoukian, David R. Kaufman, Yufan Zhao, Janet Maleski, Lance Leopold, Thomas F. Gajewski
Publicat 2015Artigo -
7
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovar... per Rebecca Kristeleit, Ірина Давиденко, Vadim Shirinkin, Fatima El-Khouly, Igor Bondarenko, Michael J. Goodheart, В. А. Горбунова, C A Penning, Jack Shi, Xiangdong Liu, Robert Newton, Yufan Zhao, Janet Maleski, Lance Leopold, Russell J. Schilder
Publicat 2017Artigo -
8
Epacadostat plus pembrolizumab in patients with advanced melanoma and select solid tumors: Updated phase 1 results from ECHO-202/KEYNOTE-037 per Tara C. Gangadhar, Omid Hamid, David C. Smith, Todd M. Bauer, Jeffrey S. Wasser, Anthony J. Olszanski, Jason J. Luke, Ani Sarkis Balmanoukian, David R. Kaufman, Yufan Zhao, Janet Maleski, Michelle Jones, L. Leopold, Thomas F. Gajewski
Publicat 2016Artigo -
9
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037) per Tara C. Mitchell, Omid Hamid, David C. Smith, Todd M. Bauer, Jeffrey S. Wasser, Anthony J. Olszanski, Jason J. Luke, Ani Sarkis Balmanoukian, Emmett V. Schmidt, Yufan Zhao, Xiaohua Gong, Janet Maleski, Lance Leopold, Thomas F. Gajewski
Publicat 2018Artigo -
10
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota per Caiji Lin, Zheng Zeng, Yiru Lin, Pengfei Wang, Danli Cao, Kaihong Xie, Yao Luo, Hao Yang, Jiaming Yang, Wenxue Wang, Lingjie Luo, Huihui Lin, Hang Chen, Yufan Zhao, Yongwei Shi, Zixiang Gao, Huidi Liu, Shu‐Lin Liu
Publicat 2022Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Cancer
Adverse effect
Cancer research
Immunotherapy
Oncology
Tolerability
Biochemistry
Biology
Clinical trial
Pembrolizumab
Pharmacology
Artificial intelligence
Clinical endpoint
Computer science
Machine learning
Melanoma
Nausea
Ovarian cancer
Pathology
Rash
Reinforcement learning
Adjunctive treatment
Allopregnanolone
Alternative medicine
Amino acid
Antioxidant
Biotechnology
Botany